Article
Up-regulated<i>MSI2</i>is associated with more aggressive chronic myeloid leukemia
3 Nov 2014
Abstract excerpt
A better understanding of events triggering chronic myeloid leukemia progression is critical for optimized clinical management of chronic myeloid leukemia (CML). We sought to validate that increased expression of Musashi 2 (MSI2), a post-transcription regulator, is associated with progression and prognosis. Screening of 152 patients with CML showed that MSI2 was significantly decreased among patients with CML in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
